Veradermics, Incorporated Common Stock (MANE)
R&D Expense Growth
-11.08%
Quarterly · Period ending:
MANE R&D Expense Growth
Latest reported-11.08%period ending
Latest reported-11.08%period ending
MANE Quarterly R&D Growth (QoQ) (0.00% → -11.08%)
Latest values, visible window
High-resolution chart · PNG
MANE r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -11.0777% | |
| 15.0231% | |
| 0.5249% | |
| 26.2963% | |
| 25.1769% | |
| 131.2525% | |
| 0% |